SK Bioscience Co Ltd Cash Flow Reinvestment Rate
SK Bioscience Co Ltd cash flow reinvestment rate. SK Bioscience Co Ltd (302440) has a Cash Flow Reinvestment Rate of 4.95x as of September 2025, reinvesting ₩102.27 Billion (capex ₩70.94 Billion plus investments ₩-31.32 Billion) from operating cash flow of ₩20.65 Billion. Explore 302440 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of SK Bioscience Co Ltd (2018–2023)
Cash flow reinvestment rate of SK Bioscience Co Ltd from 2018 to 2023. Historical reinvestment intensity for SK Bioscience Co Ltd across 5 annual periods. Explore SK Bioscience Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
SK Bioscience Co Ltd Cash Flow Reinvestment Rate by Year (2018–2023)
SK Bioscience Co Ltd cash flow reinvestment rate by year from 2018 to 2023. Year-by-year capital reinvestment analysis for SK Bioscience Co Ltd. For the full cash flow conversion analysis, see SK Bioscience Co Ltd cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 3.26x | ₩95.57 Billion | ₩29.35 Billion | ₩50.30 Billion | ▲ +22.4% |
| 2021 | 2.66x | ₩1.43 Trillion | ₩536.59 Billion | ₩42.91 Billion | ▲ +184.7% |
| 2020 | 0.93x | ₩112.32 Billion | ₩120.22 Billion | ₩9.93 Billion | ▼ -45.0% |
| 2019 | 1.70x | ₩37.06 Billion | ₩21.82 Billion | ₩23.97 Billion | ▲ +5.7% |
| 2018 | 1.61x | ₩23.95 Billion | ₩14.90 Billion | ₩6.31 Billion | — |